Tag: Dr Gisela Mautner
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
Featured Article
All eyes on Melbourne as Australian Manufacturing Week prepares to open doors
In just four weeks, the spotlight will shine on Australia’s industrial heart as Australian Manufacturing Week 2025 (AMW) takes over Melbourne’s Convention and Exhibition Centre for four days of cutting-edge tech, world-class innovation, and industry-defining conversations.
